Cecelia Health Launches PreciselyRX with Payer Matrix and Blue Genes Lab
Payer Matrix, Cecelia Health and Blue Genes Lab today announced a new integrated medication management program, PreciselyRx, to help self-funded employers manage GLP-1 coverage from the first prescription through the first year of therapy.
The web browser you are using is too old to view this site. Please update your browser or use Internet Explorer 11 or the current version of Microsoft Edge, Firefox, Chrome or Safari. Thank you!
